Locally Advanced Rectal Cancer Clinical Trial
Official title:
The Combination of Neoadjuvant Short-course Radiotherapy and Immunotherapy in Locally Advanced Rectal Cancer：A Open-label Single-arm Phase II Trial.
This is a single arm, open-label, prospective phase II clinical trial to evaluate the combination of neoadjuvant short-course radiotherapy and immunotherapy (PD-1 antibody) for patients with locally advanced rectal cancer (LARC). A total of 40 patients will be enrolled in this trial to receive 5*5Gy short-course radiotherapy, followed by 4 cycles of CAPOX chemotherapy and PD-1 antibody. Then they will receive the TME surgery and another 4 cycles of CAPOX chemotherapy. There are two cohorts according to the microsatellite instability status: (1) the micro-satellite stable (MSS) cohort（n=32), (2) the MSI-high cohort (n=8). The primary end point is the rate of pathological complete response (pCR). The long-term prognosis and adverse effects will also be evaluated and analyzed.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05079438 -
Dendrobium Huoshanense Suppository in Rectal Cancer
|
Phase 3 | |
| Recruiting |
NCT02964468 -
Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer
|
N/A | |
| Not yet recruiting |
NCT05507112 -
TIME in Immunotherapy Combined With nCRT for Rectal Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT05998122 -
Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study
|
Phase 2 | |
| Completed |
NCT04324567 -
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
|
||
| Recruiting |
NCT05412082 -
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
|
Phase 1 | |
| Recruiting |
NCT05980689 -
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
|
Phase 2 | |
| Recruiting |
NCT02605265 -
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
|
Phase 3 | |
| Terminated |
NCT02151019 -
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05086627 -
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT05076305 -
PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting
|
||
| Recruiting |
NCT03824899 -
UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT05845268 -
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
|
Phase 2 | |
| Completed |
NCT03392584 -
Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters
|
||
| Terminated |
NCT04177602 -
Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05646511 -
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE)
|
Phase 3 | |
| Terminated |
NCT02290574 -
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial
|
N/A | |
| Recruiting |
NCT03702985 -
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT05877352 -
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
|
N/A | |
| Not yet recruiting |
NCT06375434 -
Correlation Between Gut Microbiota and Radiosensitivity of Rectal Cancer
|